Ignite Creation Date:
2025-12-25 @ 2:03 AM
Ignite Modification Date:
2026-03-04 @ 11:48 AM
Study NCT ID:
NCT02903160
Status:
COMPLETED
Last Update Posted:
2024-02-07
First Post:
2016-09-07
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Prostate Cancer Intensive, Non-Cross Reactive Therapy (PRINT) for Castration Resistant Prostate Cancer (CRPC)
Sponsor:
Icahn School of Medicine at Mount Sinai
Organization:
Organization Data
Organization:
Class:
OTHER
Study ID:
GCO 16-1593
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
OTHER
Responsible Party:
Responsible Party Title:
Responsible Party Type:
PRINCIPAL_INVESTIGATOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None